CorMedix CEO Khoso Baluch's 2020 pay falls 31% to $1.2M
CorMedix reports 2020 executive compensation
By ExecPay News
Published: October 29, 2021
CorMedix reported fiscal year 2020 executive compensation information on October 29, 2021.
In 2020, six CorMedix executives received on average a compensation package of $849K, a 2% increase compared to previous year.
Average pay of disclosed executives at CorMedix
Khoso Baluch, Chief Executive Officer, received $1.2M in total, which decreased by 31% compared to 2019. 35% of Baluch's compensation, or $429K, was in option awards. Baluch also received $340K in non-equity incentive plan, $425K in salary, as well as $40K in other compensation.
Matthew David, Chief Financial Officer, received a compensation package of $1.1M. 70% of the compensation package, or $768K, was in option awards.
Phoebe Mounts, General Counsel, earned $931K in 2020, a 25% increase compared to previous year.
Elizabeth Masson-Hurlburt, Executive Vice President and Head of Clinical Operations, received $796K in 2020, which increases by 19% compared to 2019.
John Armstrong, Executive Vice President for Technical Operations, earned $787K in 2020, a 69% increase compared to previous year.
Robert W. Cook, Chief Financial Officer, received $245K in 2020, which decreases by 51% compared to 2019.
Related executives
Khoso Baluch
CorMedix
Chief Executive Officer
Matthew David
CorMedix
Chief Financial Officer
Phoebe Mounts
CorMedix
General Counsel
John Armstrong
CorMedix
Former Executive Vice President for Technical Operations
Elizabeth Masson-Hurlburt
CorMedix
Executive Vice President and Head of Clinical Operations
Robert Cook
CorMedix
Chief Financial Officer
You may also like
Source: SEC filing on October 29, 2021.